Back to AZN
OSLO PENSJONSFORSIKRING AS → AZN
OSLO PENSJONSFORSIKRING AS AZN Position History
AstraZeneca PLC • Healthcare
Quarters held
48
Latest value
$994K
Q3 2026
Peak value
$42M
First seen
Q1 2017
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2017 | $21.3M |
| Q1 2017 | $21.3M |
| Q2 2017 | $23.1M |
| Q3 2017 | $22.8M |
| Q4 2017 | $27.8M |
| Q1 2018 | $28.1M |
| Q2 2018 | $28.2M |
| Q3 2018 | $31.6M |
| Q4 2018 | $30.4M |
| Q1 2019 | $32.4M |
| Q2 2019 | $33.3M |
| Q3 2019 | $35.9M |
| Q4 2019 | $40.2M |
| Q1 2020 | $35.9M |
| Q2 2020 | $42M |
| Q3 2020 | $36.4M |
| Q4 2020 | $33.3M |
| Q1 2021 | $33.1M |
| Q2 2021 | $39.7M |
| Q3 2021 | $39.8M |
| Q4 2021 | $38.7M |
| Q1 2022 | $29.6M |
| Q2 2022 | $29.1M |
| Q3 2022 | $24.6M |
| Q4 2022 | $29.7M |
| Q1 2023 | $30.7M |
| Q2 2023 | $31.7M |
| Q3 2023 | $30.3M |
| Q4 2023 | $29.7M |
| Q1 2024 | $30M |
| Q2 2024 | $34.7M |
| Q2 2024 | $459K |
| Q3 2024 | $34.3M |
| Q3 2024 | $504K |
| Q4 2024 | $28.9M |
| Q4 2024 | $530K |
| Q1 2025 | $32.1M |
| Q1 2025 | $546K |
| Q2 2025 | $30.8M |
| Q2 2025 | $521K |
| Q3 2025 | $33.4M |
| Q3 2025 | $566K |
| Q4 2025 | $40.8M |
| Q4 2025 | $697K |
| Q2 2026 | $41.5M |
| Q2 2026 | $1.1M |
| Q3 2026 | $36.1M |
| Q3 2026 | $994K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $994K | 6.1K | — | — |
| Q3 2026 | $36.1M | 220.9K | — | — |
| Q2 2026 | $1.1M | 6.1K | — | — |
| Q2 2026 | $41.5M | 220.9K | — | — |
| Q4 2025 | $697K | 3.8K | — | — |
| Q4 2025 | $40.8M | 220.9K | — | — |
| Q3 2025 | $566K | 3.8K | — | — |
| Q3 2025 | $33.4M | 220.9K | — | — |
| Q2 2025 | $521K | 3.8K | — | — |
| Q2 2025 | $30.8M | 220.9K | — | — |
| Q1 2025 | $546K | 3.8K | — | — |
| Q1 2025 | $32.1M | 220.9K | — | — |
| Q4 2024 | $530K | 4.0K | — | — |
| Q4 2024 | $28.9M | 220.9K | — | — |
| Q3 2024 | $504K | 3.2K | — | — |
| Q3 2024 | $34.3M | 220.9K | — | — |
| Q2 2024 | $459K | 2.9K | — | — |
| Q2 2024 | $34.7M | 220.9K | — | — |
| Q1 2024 | $30M | 220.9K | — | — |
| Q4 2023 | $29.7M | 220.9K | — | — |
| Q3 2023 | $30.3M | 220.9K | — | — |
| Q2 2023 | $31.7M | 220.9K | — | — |
| Q1 2023 | $30.7M | 220.9K | — | — |
| Q4 2022 | $29.7M | 220.9K | — | — |
| Q3 2022 | $24.6M | 220.9K | — | — |
| Q2 2022 | $29.1M | 220.9K | — | — |
| Q1 2022 | $29.6M | 220.9K | — | — |
| Q4 2021 | $38.7M | 330.0K | — | — |
| Q3 2021 | $39.8M | 330.0K | — | — |
| Q2 2021 | $39.7M | 330.0K | — | — |
| Q1 2021 | $33.1M | 330.0K | — | — |
| Q4 2020 | $33.3M | 330.0K | — | — |
| Q3 2020 | $36.4M | 330.0K | — | — |
| Q2 2020 | $42M | 400.0K | — | — |
| Q1 2020 | $35.9M | 400.0K | — | — |
| Q4 2019 | $40.2M | 400.0K | — | — |
| Q3 2019 | $35.9M | 400.0K | — | — |
| Q2 2019 | $33.3M | 400.0K | — | — |
| Q1 2019 | $32.4M | 400.0K | — | — |
| Q4 2018 | $30.4M | 400.0K | — | — |
| Q3 2018 | $31.6M | 400.0K | — | — |
| Q2 2018 | $28.2M | 400.0K | — | — |
| Q1 2018 | $28.1M | 400.0K | — | — |
| Q4 2017 | $27.8M | 400.0K | — | — |
| Q3 2017 | $22.8M | 340.0K | — | — |
| Q2 2017 | $23.1M | 340.0K | — | — |
| Q1 2017 | $21.3M | 340.0K | — | — |
| Q1 2017 | $21.3M | 340.0K | — | — |